A method for constructing an animal model of LncRNA XIST gene knock-in based on RNA targeting binding sites

Based on the target binding site of LncRNA XIST and microRNA mmu-miR-140-5p, the length of knock-in fragments of CRISPR/Cas9 technology was shortened, and the problem of high off-target rate during knock-in of LncRNA XIST gene in traditional technology was solved. , realizes efficient animal model construction, suitable for studying the regulation of LncRNA and microRNA.

CN114783509BActive Publication Date: 2024-11-19AFFILIATED HOSPITAL OF GUILIN MEDICAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210422417.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-04-21
Publication Date
2024-11-19
Estimated Expiration
2042-04-21

AI Technical Summary

Technical Problem

When traditional CRISPR/Cas9 technology knocked in the LncRNA XIST gene that had a length of up to 17.9 kb and contained seven exons, the gene off-target rate caused by excessive fragments, making it difficult to effectively build an animal model.

Method used

Through bioinformatics analysis and in vitro experiments, LncRNA XIST and microRNA mmu-miR-140-5p target binding sites were confirmed, and CRISPR/Cas9 technology based on the seventh exon was designed to shorten the knock-in fragment length to 7.6kb to achieve Accurate knock-in of the LncRNA XIST gene.

Benefits of technology

It significantly reduces the off-target rate of gene knock-in, improves the positive rate of mouse progeny and the success rate of model construction, provides better research conditions, and is suitable for studying the downstream signaling molecular mechanisms of LncRNA and microRNA.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114783509B_ABST
    Figure CN114783509B_ABST
Patent Text Reader

Abstract

This invention discloses a method for constructing an LncRNA XIST gene knock-in animal model based on RNA targeting binding sites. The method includes bioinformatics analysis of the XIST gene and the mmu-miR-140-5p targeting binding site in the seventh exon of the XIST gene; in vitro experiments confirming the targeting binding site of the XIST gene and mmu-miR-140-5p in the bioinformatics analysis; construction of an sgRNA vector targeting the seventh exon of the mouse XIST gene containing the targeting binding site; in vitro transcription of the sgRNA; acquisition and identification of F0 generation mice; acquisition and identification of F1 generation heterozygous mice; and the acquisition of homozygous offspring. This method solves the problem of high off-target rates caused by excessively long fragments during the knock-in of XIST genes (up to 17.9 kb with seven exons) using CRISPR / Cas9.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The invention belongs to the technical field of bioengineering, and in particular relates to a method for constructing an LncRNAXIST gene knock-in animal model based on RNA targeting binding sites. [Background technology]

[0002] The CRISPR / Cas system is a technology derived from bacterial acquired immunity that uses RNA to mediate Cas proteins to target and modify target genes. The Type Ⅱ CRISPR / Cas9 system, which has been modified by researchers, has been used to knock out genes in a variety of model organisms since it successfully knocked out mammalian cells in 2013. The CRISPR / Cas9 system vector is simple and fast to construct, easy to operate, time-saving and labor-saving, and has a short cycle, and is applicable to almost all species. The functions of CRISPR / Cas9 and TALEN (Transcription Activator-like Effector Nucleases) are to achieve double-strand breaks at specific sites on chromosomes, and then trigger autonomous damage repair, which will cause insertions or deletions, resulting in permanent deletions of gene sequences, i.e. gene knockout. For each gene, CRISPER / Cas9 only needs to construct one sgRNA (single guide RNA), and the efficiency is very high, and the sequence selection restrictions are relatively small, and only GG needs to appear on the genome. Compared with zinc finger nuclease (ZFN) and TALEN, CRISPER / Cas9 causes higher off-target effects, but the use of paired sgRNA / Cas9-D10A> truncated sgRNA or FoKI-dCas9 can greatly reduce off-target effects. Currently, CRISPER / Cas9 is mainly used for gene site-directed mutation (insertion or deletion), gene site-directed knockout, simultaneous mutation of two sites, deletion of small fragments, and targeted gene knockout of coding genes and non-coding genes (lncRNA, microRNA).

[0003] At present, the schemes for constructing knockout or knock-in gene experimental animals basically adopt the method of knocking out the full-length or partial genes encoding RNA and protein, and there is no proprietary scheme designed for the characteristics of non-coding RNA. Non-coding RNA usually exerts its function through mature RNA after transcription, rather than the final encoded protein like protein-coding genes. As a type of non-coding RNA, lncRNA generally exerts its function by directly binding to the target microRNA at a site of about 10 bases. Therefore, we can design knockout or knock-in schemes based on the predicted location of the target binding site of lncRNA and microRNA. This can reduce the difficulty of gene knock-in caused by the long length of lncRNA and the presence of multiple exons, and realize our research on the role of lncRNA in targeting and binding microRNA. [Summary of the invention]

[0004] Aiming at the problem of high gene off-target rate caused by too long fragments in the knock-in process of LncRNA XIST gene with a full length of 17.9kb and seven exons by traditional CRISPR / Cas9 technology in the prior art, the present invention provides a method for constructing an LncRNA XIST gene knock-in animal model based on RNA targeting binding sites, and is a method for constructing an LncRNA XIST gene knock-in animal model based on CRISPR / Cas9 technology targeting binding sites of LncRNA XIST and microRNA mmu-miR-140-5p. By knocking in the exon of LncRNA containing LncRNA and microRNA targeting binding sites, the purpose of studying the effect of LncRNA targeting binding to microRNA is achieved, the difficulty of gene knock-in caused by LncRNA being too long and containing multiple exons is reduced, and the research on the effect of LncRNA targeting binding to microRNA is realized.

[0005] The purpose of the present invention is achieved through the following technical solutions:

[0006] A method for constructing an LncRNA XIST gene knock-in animal model based on RNA targeting binding sites comprises the following steps:

[0007] 1) Bioinformatics analysis was performed using the starbase database to confirm the target binding site information of LncRNA XIST and microRNA mmu-miR-140-5p;

[0008] 2) Compare the location of the above-mentioned target binding site in the LncRNA XIST gene using the NCBI database;

[0009] 3) Compare the above-mentioned target binding site in the seventh exon of the LncRNA XIST gene through the NCBI database;

[0010] 4) The dual luciferase gene reporter system was used to confirm the existence of the LncRNAXIST and microRNA mmu-miR-140-5p target binding sites shown in the above database in in vitro experiments;

[0011] 5) LncRNA XIST is 17.9 kb in length. Based on its seventh exon (length 7.6 kb), a knock-in strategy for LncRNA XIST was designed based on the targeted binding site of LncRNA XIST and microRNAs mmu-miR-140-5p;

[0012] 6) The knock-in of LncRNA XIST gene was achieved by knocking in the seventh exon of LncRNA XIST.

[0013] In the present invention:

[0014] Furthermore, step 1) is to confirm that LncRNAs (such as LncRNAXIST) and microRNAs (such as mmu-miR-140-5p) with sequence lengths exceeding 10 kb and containing multiple exons have target binding sites in bioinformatics analysis and in vitro experiments.

[0015] Furthermore, step 2) is to confirm that LncRNA XIST (length 17.9 kb) and mmu-miR-140-5p have a targeted binding site in bioinformatics analysis and in vitro experiments.

[0016] Furthermore, step 4) is to confirm in bioinformatics analysis and in vitro experiments that the seventh exon (length 7.6 kb) of LncRNA XIST has targeted binding with mmu-miR-140-5p.

[0017] Furthermore, step 5) is that the seventh exon of LncRNA XIST is targeted to bind to mmu-miR-140-5p, and based on the RNA targeted binding site, the nucleic acid fragment that should have been knocked in with a length of 17.9 kb is shortened to a nucleic acid fragment with a length of 7.6 kb, thereby effectively reducing the off-target rate of LncRNA XIST knock-in. Step 5) specifically includes:

[0018] ① Bioinformatics analysis revealed the base sequence information of the target binding sites of LncRNA XIST and microRNAs mmu-miR-140-5p;

[0019] ② Determine that the base sequence of the binding site is located in the seventh exon of LncRNA XIST;

[0020] ③ The length of the seventh exon of LncRNA XIST was determined to be 7.6kb, which is greatly shortened compared to the full length of LncRNA XIST (17.9kb);

[0021] ④ The in vitro dual luciferase gene reporter system confirmed the existence of the target binding site between LncRNA XIST and microRNA mmu-miR-140-5p.

[0022] Step 5) The same scheme as the traditional CRISPR / Cas9 technology was used to knock in the seventh exon of LncRNA XIST to achieve knock-in of the LncRNA XIST gene, so as to better study the molecular mechanism of targeted binding and regulation of downstream signals by LncRNA XIST and microRNAsmmu-miR-140-5p in animal models.

[0023] Compared with the prior art, the present invention has the following advantages:

[0024] 1. The method for constructing an LncRNA XIST gene knock-in animal model based on RNA targeting binding sites described in the present invention is a method for constructing an LncRNA XIST gene knock-in animal model based on CRISPR / Cas9 technology targeting binding sites of LncRNA XIST and microRNA mmu-miR-140-5p, comprising bioinformatics analysis of the LncRNA XIST gene and microRNA mmu-miR-140-5p targeting binding sites in the seventh exon of the LncRNA XIST gene, in vitro experimental dual luciferase gene reporter system confirmation of the real existence of the binding site, construction of an sgRNA vector targeting the seventh exon of the mouse LncRNA XIST gene containing the targeting binding site, in vitro transcription of the sgRNA, acquisition and identification of F0 generation mice, acquisition and identification of F1 generation heterozygous mice, acquisition of homozygous offspring, and the like. The XIST gene knock-in animal model, the constructed animal model, solves the problem of high gene off-target rate caused by too long fragments during the knock-in process of the LncRNAXIST gene with a total length of 17.9kb and seven exons by the traditional CRISPR / Cas9 technology, by only knocking in the seventh exon containing the LncRNAXIST and microRNA mmu-miR-140-5p targeting binding site, and reducing the length of the knock-in fragment to 7.6kb without affecting the research effect, and better studying the molecular mechanism of LncRNA XIST and microRNAmmu-miR-140-5p targeting binding regulation of downstream signals in the animal model. The method described in the present invention extremely efficiently reduces the off-target rate, improves the positive rate of mouse offspring and the success rate of model construction, so that the animal model constructed by the method of the present invention has good practicality, and has important application value in various disease mechanism research and drug development fields.

[0025] 2. The method for constructing an LncRNA XIST gene knock-in animal model based on RNA targeting binding sites described in the present invention is not limited to studying the molecular mechanism of LncRNA XIST and microRNA mmu-miR-140-5p targeting binding to regulate downstream signals, but has good effects on the same type of LncRNAs (length exceeding 10kb and containing multiple exons). Based on the binding sites of LncRNAs and microRNAs, this method can also effectively reduce the length of LncRNAs knocked in of the same type, avoiding the high off-target rate of gene knock-in mice in related studies.

[0026] 3. The invention discloses a method for constructing an animal model of LncRNA XIST gene knock-in based on RNA targeting binding sites. The innovation of the invention is that the full length of LncRNA XIST that should be knocked in is greatly shortened to 7.6 kb for the seventh exon, which greatly shortens the length of the base sequence and reduces the off-target rate. That is to say, the method of the invention effectively avoids the problem of too high off-target rate caused by too long bases in the knock-in gene sequence of the classic CRISPR / Cas9 technology. The specific knock-in process is no different from the knock-in gene of the classic CRISPR / Cas9 technology, but the LncRNA XIST gene that should be knocked in with a full length of 17.9 kb is changed to only knocking in the 7th exon 7.6 kb.

Brief Description of the Drawings

[0027] Figure 1 This is a diagram of bioinformatics analysis using the starbase database to confirm the targeted binding site information of LncRNAXIST and microRNA mmu-miR-140-5p in an embodiment of the present invention;

[0028] Figure 2 This is a picture that confirms the real existence of the binding site through in vitro dual luciferase gene reporter system;

[0029] Figure 3 is a diagram of the position of the above-mentioned target binding site in the LncRNA XIST gene compared through the NCBI database in an embodiment of the present invention;

[0030] Figure 4 This is a diagram of comparing the above-mentioned target binding site in the seventh exon of the LncRNA XIST gene through the NCBI database in an embodiment of the present invention;

[0031] Figure 5 This is a diagram of the LncRNA XIST gene knock-in strategy designed based on the LncRNA XIST and microRNAs mmu-miR-140-5p targeted binding site according to the seventh exon (length 7.6 kb) of the present invention. [Specific implementation method]

[0032] The specific implementation modes of the present invention are further described below in conjunction with examples.

[0033] Example:

[0034] 1. A method for constructing an animal model of LncRNA XIST gene knock-in based on RNA targeting binding sites:

[0035] 1) Use the starbase database for bioinformatics analysis to confirm the target binding site information of LncRNA XIST and microRNA mmu-miR-140-5p, specifically LncRNAs (such as LncRNA XIST) and microRNAs (such as mmu-miR-140-5p) with sequence lengths exceeding 10kb and containing multiple exons that have been confirmed to have target binding sites in bioinformatics analysis and in vitro experiments;

[0036] 2) The location of the above-mentioned target binding site in the LncRNA XIST gene was compared through the NCBI database, specifically LncRNA XIST (length 17.9 kb) and mmu-miR-140-5p were confirmed to have a target binding site in bioinformatics analysis and in vitro experiments;

[0037] 3) Compare the above-mentioned target binding site in the seventh exon of the LncRNA XIST gene through the NCBI database;

[0038] 4) The dual luciferase gene reporter system was used to confirm in vitro that the LncRNAXIST and microRNA mmu-miR-140-5p target binding sites shown in the above database are real. Specifically, LncRNA XIST was confirmed in bioinformatics analysis and in vitro experiments to have a targeted binding with mmu-miR-140-5p in its seventh exon (7.6 kb in length);

[0039] 5) The total length of LncRNA XIST is 17.9 kb. According to its seventh exon (length 7.6 kb), a LncRNA XIST gene knock-in strategy based on the targeted binding site of LncRNAXIST and microRNAs mmu-miR-140-5p was designed. Specifically, the seventh exon of LncRNA XIST was targeted to bind with mmu-miR-140-5p. Based on the RNA targeted binding site, the nucleic acid fragment of 17.9 kb that should have been knocked in was shortened to a nucleic acid fragment of 7.6 kb in length, which effectively reduced the off-target rate of LncRNA XIST knock-in. More specifically, the following steps were included:

[0040] ① Bioinformatics analysis revealed the base sequence information of the target binding sites of LncRNA XIST and microRNAs mmu-miR-140-5p;

[0041] ② Determine that the base sequence of the binding site is located in the seventh exon of LncRNA XIST;

[0042] ③ The length of the seventh exon of LncRNA XIST was determined to be 7.6kb, which is greatly shortened compared to the full length of LncRNA XIST (17.9kb);

[0043] ④ The in vitro dual luciferase gene reporter system confirmed the existence of the LncRNA XIST and microRNA mmu-miR-140-5p target binding sites;

[0044] 6) The knock-in of LncRNA XIST gene was achieved by knocking in the seventh exon of LncRNA XIST.

[0045] Figure 1 :Use the starbase database for bioinformatics analysis to confirm the target binding site information of LncRNA XIST and microRNA mmu-miR-140-5p. Use a browser to open the starbase database online link: https: / / starbase.sysu.edu.cn / ; enter LncRNA XIST and mmu-miR-140-5p in the search bar; click the search button, and the starbase database will quickly output the base-related information of the target binding site of LncRNA XIST and microRNA mmu-miR-140-5p.

[0046] Figure 2 :The in vitro dual luciferase gene reporter system confirmed the existence of the target binding site. The pmirGLO dual luciferase reporter gene vector of Promega was used to construct the dual luciferase gene reporter system plasmids pmirGLO-XIST-WT (wild type) and pmirGLO-XIST-MUT (mutant type). The operation process was in accordance with the instructions. The cells were inoculated in a 6-well plate, and the experiment was divided into 4 groups:

[0047] ①mmu-miR-140-5p mimics+pmirGLO-XIST-WT group;

[0048] ②miR-NC+pmirGLO-XIST-WT group;

[0049] ③mmu-miR-140-5p mimics+pmirGLO-XIST-MUT group;

[0050] ④miR-NC+pmirGLO-XIST-MUT group;

[0051] Use of Lipofectamine TMCo-transfect the pmirGLO-XIST-WT / pmirGLO-XIST-MUT plasmids and miR-320mimics / miR-NC with 3000 μL of transfection reagent and use them after 24 hours. The Reporter Assay System (Promega) kit was used to detect changes in luciferase activity. The specific operation was carried out according to the instruction manual. The experiment was repeated 3 times, and the data were counted and analyzed to confirm the existence of the above-mentioned target binding site.

[0052] Figure 3 :Compare the location of the above-mentioned target binding site in the LncRNA XIST gene through the NCBI database, and use the browser to open the NCBI database online link: https: / / www.ncbi.nlm.nih.gov / ; click in the search bar Nucleotide Click the Blast button to enter the base sequence comparison search interface; enter Figure 1 Find the base sequence of LncRNA XIST, the binding site in the middle, click the Blast comparison button; find the link of the mouse LncRNA XIST information displayed on the web page; click the above link to obtain the specific location information of the targeted binding site in the LncRNA XIST gene.

[0053] Figure 4 :Compare the above-mentioned target binding site in the seventh exon of LncRNA XIST gene through the NCBI database, and use the browser to open the NCBI database online link: https: / / www.ncbi.nlm.nih.gov / ; in the search box Select gene search Enter LncRNA XIST and click the search button; find the link of mouse LncRNA XIST information on the web page; click the above link to obtain the specific location information of the LncRNA XIST gene, and click the button that displays the genbank format to obtain the information of the above target binding site in the seventh exon of the LncRNA XIST gene.

[0054] Figure 5 :LncRNA XIST is 17.9kb in length. Based on its seventh exon (length 7.6kb), a knock-in strategy for LncRNA XIST was designed based on the targeting binding site of LncRNA XIST and microRNAs mmu-miR-140-5p. Figure 3 The search information found that LncRNA XIST contains seven exons, and the above-mentioned targeted binding site is located in its seventh exon; use PowerPoint to draw a simple diagram of the LncRNA XIST gene containing seven exons and mark the position of the seventh exon; use a red box to mark the knock-in information of the seventh exon of the LncRNA XIST gene at the targeted binding site.

[0055] 2. Results

[0056] 2.1 Prediction of targets of LncRNA XIST and mmu-miR-140-5p

[0057] Through Starbase database retrieval, it was found that in the process of predicting the targeting relationship between LncRNA XIST and mmu-miR-140-5p, the prediction software miRanda was used, the CLIP Data parameter was set to 3, and the Pan-Cancer parameter of miRNA-lncRNA interaction was set to 5. The results showed that LncRNA XIST and mmu-miR-140-5p had a tight targeting binding site, that is, LncRNA XIST may regulate the expression of downstream target genes by sponging mmu-miR-140-5p.

[0058] 2.2 Cell experiments verify that LncRNA XIST can bind to mmu-miR-140-5p

[0059] By constructing a dual luciferase gene reporter system targeting the predicted binding site and transfecting the system into A549 cells, the luciferase activity changes were detected using a luciferase activity detection kit. The results showed that when mmu-miR-140-5p was transfected into the XIST-WT (unmutated binding site) and XIST-MUT (mutated binding site) groups, the luciferase activity of the XIST-MUT group was significantly increased; at the same time, when the mmu-miR-140-5p inhibitor was transfected into the XIST-WT (unmutated binding site) and XIST-MUT (mutated binding site) groups, the luciferase activity of the XIST-MUT group was significantly decreased. In vitro experiments confirmed that LncRNAXIST binds to mmu-miR-140-5p through the predicted binding site.

[0060] 2.3 NCBI database shows the location information of binding sites in LncRNA XIST

[0061] The base sequences of the above LncRNA XIST and mmu-miR-140-5p target binding sites were entered into the NCBI database Nucleotide Blast (nucleic acid sequence alignment) software was used to search and the results showed that the binding site was located at The base positions of LncRNA XIST gene are 14267-14287; the mouse LncRNA XIST gene is searched through the NCBI database, and its genbank format file is opened. The results show that the base positions of LncRNA XIST gene are 14267-14287, which are located in the 7th exon of the gene.

[0062] 2.4 LncRNA XIST knock-in strategy for the binding site between LncRNA XIST and mmu-miR-140-5p

[0063] Through the search of NCBI database genbank, it was found that the LncRNA XIST gene contains 7 exons and 6 introns, based on which we can roughly draw a schematic diagram of the LncRNA XIST gene. Based on the fact that the binding site of LncRNA XIST and mmu-miR-140-5p is located in the 7th exon of the gene, we can reduce the original 17.9kb LncRNA XIST knock-in (which can hardly be knocked in using CRISPR / Cas9 technology, i.e., the off-target rate may be 100%) to only knock-in the 7th exon of LncRNAXIST with a length of 7.6kb (which can be knocked in using CRISPR / Cas9 technology, with a low off-target rate).

[0064] The present invention utilizes the bioinformatics analysis technology of targeted binding of LncRNAs and microRNAs in combination with in vitro experimental data to determine the real existence of the targeted binding site of LncRNA XIST and mmu-miR-140-5p; as well as the base sequence information of the targeted binding site on the LncRNA XIST gene; as well as the position of the base sequence on the LncRNA XIST gene at 14267-14287; and as well as the position in the 7th exon of the LncRNA XIST gene.

[0065] The problem of too high off-target rate caused by too long bases in knocking in gene sequences with the classic CRISPR / Cas9 technology was effectively avoided. The LncRNA XIST gene that was supposed to be knocked in with a full length of 17.9kb was changed to only knocking in the 7th exon 7, which was 7.6kb long. This allowed the study of LncRNA XIST regulating downstream target genes by sponging mmu-miR-140-5p, and participating in the regulation of a series of physiological behaviors of cell proliferation, apoptosis and differentiation.

[0066] In summary, the present invention provides a method for constructing an LncRNA XIST gene knock-in animal model based on RNA targeting binding sites. By shortening the base length of the LncRNA XIST gene knock-in sequence, the LncRNA XIST adsorbed mmu-miR-140-5p to participate in the regulation of cell physiological behaviors closely related to various diseases through animal experiments without affecting the experimental results.

[0067] The above description is a detailed description of the preferred feasible embodiments of the present invention, but the embodiments are not intended to limit the scope of the patent application of the present invention. All equivalent changes or modified changes completed under the technical spirit suggested by the present invention should fall within the patent scope covered by the present invention.

Claims

1. A method for constructing an animal model of LncRNA XIST gene knock-in based on RNA targeting binding sites, characterized in that: The steps include: 1) Bioinformatics analysis was performed using the starbase database to confirm the target binding site information of LncRNA XIST and microRNA mmu-miR-140-5p; 2) Compare the location of the above-mentioned target binding sites in the LncRNA XIST gene using the NCBI database; 3) Compare the above-mentioned target binding site in the seventh exon of the LncRNA XIST gene through the NCBI database; 4) The dual luciferase gene reporter system was used to confirm the existence of the LncRNA XIST and microRNA mmu-miR-140-5p target binding sites shown in the above database in in vitro experiments; 5) The full length of LncRNA XIST is 17.9 kb. Based on its seventh exon, a LncRNA XIST gene knock-in strategy based on the LncRNA XIST and microRNAsmmu-miR-140-5p targeted binding site was designed; the length of the seventh exon is 7.6 kb; 6) Knock-in of the LncRNA XIST gene by knocking in the seventh exon of LncRNA XIST; Step 5) is that the seventh exon of LncRNA XIST is targeted to bind to mmu-miR-140-5p. Based on the RNA targeted binding site, the nucleic acid fragment that should have been knocked in with a length of 17.9 kb is shortened to a nucleic acid fragment with a length of 7.6 kb, effectively reducing the off-target rate of LncRNA XIST knock-in. Specifically, the following steps are included: ① Bioinformatics analysis revealed the base sequence information of the target binding sites of LncRNA XIST and microRNAs mmu-miR-140-5p; ② Determine that the base sequence of the binding site is located in the seventh exon of LncRNA XIST; ③ The length of the seventh exon of LncRNA XIST was determined to be 7.6kb, which is greatly shortened compared to the full length of LncRNA XIST (17.9kb); ④ The in vitro dual luciferase gene reporter system confirmed the existence of the target binding site between LncRNA XIST and microRNA mmu-miR-140-5p.

2. The method for constructing an LncRNA XIST gene knock-in animal model based on RNA targeting binding sites according to claim 1, characterized in that: Step 1) LncRNAs and microRNAs with sequence lengths exceeding 10 kb and containing multiple exons are confirmed to have targeted binding sites in bioinformatics analysis and in vitro experiments; the LncRNAs is LncRNA XIST, and the microRNAs is mmu-miR-140-5p.

3. The method for constructing an LncRNA XIST gene knock-in animal model based on RNA targeting binding sites according to claim 1, characterized in that: Step 2) LncRNA XIST and mmu-miR-140-5p are confirmed to have a targeted binding site in bioinformatics analysis and in vitro experiments; the length of the LncRNA XIST is 17.9 kb.

4. The method for constructing an LncRNA XIST gene knock-in animal model based on RNA targeting binding sites according to claim 1, characterized in that: Step 4) LncRNA XIST was confirmed in bioinformatics analysis and in vitro experiments that its seventh exon was targeted and bound to mmu-miR-140-5p; the length of the seventh exon was 7.6 kb.